Related Articles
00 / 00
Request an Appointment
President & CEO, Fox Chase Cancer Center
Executive Vice President for Cancer Services – Temple University Health System
Senior Associate Dean, Clinical Cancer Research – Lewis Katz School of Medicine at Temple University
G. Willing "Wing" Pepper Chair in Cancer Research
Adrenal Tumor, Penile Cancer, Ureteral Cancer, Kidney Cancer, Testicular Cancer, Bladder Cancer, Prostate Cancer, Urethral Cancer
I believe in treating patients as I would my own family. I strive to communicate effectively with patients and family members at all levels. Through extensive discussions with my patients, I develop treatment plans that are both effective and acknowledge that quality of life issues are exceptionally important. I emphasize individually tailored treatments to help patients achieve success and limit treatment-related side effects which can affect quality of life.
I am sensitive to the particular issues regarding surgical treatment of genitourinary cancer, especially the physical and emotional effects on patients and their family. By fostering a doctor-patient relationship based on mutual respect and open dialogue, I encourage patients to become empowered managers of their care... Expand
As a fellowship-trained laparoscopic and robotic urologic oncologist, I am specially trained in nerve-sparing, organ sparing and organ reconstructive surgical techniques for men and women. These strategies are essential for preserving normal functions. For instance, I perform kidney sparing surgery whenever possible to avoid future risks of dialysis. For prostate or testicular surgery, nerve preservation is essential; and when bladder removal is necessary, reconstruction of a new (neobladder) is my preferred approach.
Professionally, I have published more than 300 journal papers in urologic oncology and have lectured extensively regionally, nationally and internationally on the topics of kidney, prostate, bladder, and testicular cancer. I am the principle investigator or co-investigator on multiple national and regional clinical trials in urologic oncology. Because of my research and extensive membership in professional organizations, I am among the first to know what is new in urologic cancer treatment. Philadelphia magazine has chosen me for its "Top Doctors" list every year since 2002. Collapse
Uzzo’s primary research has been in renal cell carcinoma, with a special focus on clinical decision making, surgical management, and adjuvant therapies. He has been a principal investigator, investigator, or co-principal investigator on dozens of leading national and international trials in urinary cancers that have had a major impact on the field of urology. In addition, he is the developer of the NEPHROMETRY scoring system, which is used to delineate the complexity of renal tumors and impact of care.
Uzzo is a diplomat of the American Board of Urology, a fellow of the American College of Surgeons, and an elected member of both the prestigious American Association of Genitourinary Surgeons and the Clinical Society of GU Surgeons. He has served as visiting professor at over 50 institutions around the world, trained dozens of residents and fellows, holds six patents, and has been principal investigator or co-principal investigator on dozens of grants. His publication of over 900 peer reviewed articles, chapters and abstracts have been cited nearly 20,000 times in the literature
Uzzo graduated summa cum laude and as valedictorian from Union College’s accelerated six-year Biomedical Program. He attended Cornell University Medical College, where he was a New York State Finalist for the Rhodes Scholarship competition. He completed general surgical training followed by urologic surgical training at New York-Presbyterian/Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center. He was an American Foundation for Urological Diseases Scholar in Urological Oncology and completed both oncological and renal transplantation fellowships at Cleveland Clinic before joining Fox Chase in 2000.
I follow up with people and act as a mentor. I let them know they are able to contact me at any time, and I can offer them peace of mind from someone who has been where they are headed.
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 14.0px Calibri; -webkit-text-stroke: #000000} span.s1 {font-kerning: none}
Pollack A., Hanlon A.L., Horwitz E.M., Feigenberg S.J., Konski A.A., Movsas B., Greenberg R.E., Uzzo R.G., Ma C.-M.C., McNeeley S.W., Buyyounouski M.K., Price Jr. R.A., Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial, 2006, International Journal of Radiation Oncology Biology Physics, 64, 2, 518, 526 PubMed
Qiao J., Uzzo R., Obara-Ishihara T., Degenstein L., Fuchs E., Herzlinger D., FGF-7 modulates ureteric bud growth and nephron number in the developing kidney, 1999, Development, 126, 3, 547, 554
Lane B.R., Russo P., Uzzo R.G., Hernandez A.V., Boorjian S.A., Thompson R.H., Fergany A.F., Love T.E., Campbell S.C., Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function, 2011, Journal of Urology, 185, 2, 421, 427 PubMed
Mann S.J., Pickering T.G., Sos T.A., Uzzo R.G., Sarkar S., Friend K., Rackson M.E., Laragh J.H., Captopril renography in the diagnosis of renal artery stenosis: accuracy and limitations, 1991, The American Journal of Medicine, 90, 1, 30, 40 PubMed
Dulaimi E., Uzzo R.G., Greenberg R.E., Al-Saleem T., Cairns P., Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel, 2004, Clinical Cancer Research, 10, 6, 1887, 1893 PubMed
Kunkle D.A., Crispen P.L., Chen D.Y.T., Greenberg R.E., Uzzo R.G., Enhancing Renal Masses With Zero Net Growth During Active Surveillance, 2007, Journal of Urology, 177, 3, 849, 854 PubMed
Touijer K., Jacqmin D., Kavoussi L.R., Montorsi F., Patard J.J., Rogers C.G., Russo P., Uzzo R.G., Van Poppel H., The Expanding Role of Partial Nephrectomy: A Critical Analysis of Indications, Results, and Complications, 2010, European Urology, 57, 2, 214, 222 PubMed Collapse
The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.
Patient comments